[go: up one dir, main page]

FI955224L - Hepatiitti-C-virustyypit 4,5 ja 6 - Google Patents

Hepatiitti-C-virustyypit 4,5 ja 6 Download PDF

Info

Publication number
FI955224L
FI955224L FI955224A FI955224A FI955224L FI 955224 L FI955224 L FI 955224L FI 955224 A FI955224 A FI 955224A FI 955224 A FI955224 A FI 955224A FI 955224 L FI955224 L FI 955224L
Authority
FI
Finland
Prior art keywords
hepatitis
virus types
virus
types
Prior art date
Application number
FI955224A
Other languages
English (en)
Swedish (sv)
Other versions
FI118688B (fi
FI955224A0 (fi
Inventor
Peter Simmonds
Peng Lee Yap
Ian Hugo Pike
Original Assignee
Common Services Agency
Murex Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939309237A external-priority patent/GB9309237D0/en
Priority claimed from GB9400263A external-priority patent/GB9400263D0/en
Application filed by Common Services Agency, Murex Diagnostics Ltd filed Critical Common Services Agency
Publication of FI955224A0 publication Critical patent/FI955224A0/fi
Publication of FI955224L publication Critical patent/FI955224L/fi
Application granted granted Critical
Publication of FI118688B publication Critical patent/FI118688B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
FI955224A 1993-05-05 1995-11-01 Hepatiitti-C-virustyypit 4,5 ja 6 FI118688B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9309237 1993-05-05
GB939309237A GB9309237D0 (en) 1993-05-05 1993-05-05 Hepatitis-c virus type 4 and 6
GB9400263 1994-01-07
GB9400263A GB9400263D0 (en) 1994-01-07 1994-01-07 Hepatitis-C virus type 4,5 & 6
PCT/GB1994/000957 WO1994025602A1 (en) 1993-05-05 1994-05-05 Hepatitis-c virus type 4, 5 and 6
GB9400957 1994-05-05

Publications (3)

Publication Number Publication Date
FI955224A0 FI955224A0 (fi) 1995-11-01
FI955224L true FI955224L (fi) 1995-12-20
FI118688B FI118688B (fi) 2008-02-15

Family

ID=26302858

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955224A FI118688B (fi) 1993-05-05 1995-11-01 Hepatiitti-C-virustyypit 4,5 ja 6

Country Status (9)

Country Link
US (4) US6881821B2 (fi)
EP (1) EP0698101B1 (fi)
JP (3) JP3751315B2 (fi)
AT (1) ATE281526T1 (fi)
AU (1) AU695259B2 (fi)
DE (1) DE69434116T2 (fi)
ES (1) ES2231773T3 (fi)
FI (1) FI118688B (fi)
WO (1) WO1994025602A1 (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881821B2 (en) * 1993-05-05 2005-04-19 Common Services Agency Hepatitis-C virus type 4, 5, and 6
ES2232815T5 (es) 1993-05-10 2009-06-15 Novartis Vaccines And Diagnostics, Inc. Metodos de tipado del virus de la hepatitis c y reactivos para usar en los mismos.
GB2294690B (en) * 1994-11-01 1998-10-28 United Biomedical Inc Peptides effective for diagnosis and detection of hepatitis C infection
CA2251977A1 (en) 1996-04-19 1997-10-30 The Government Of The United States Of America, As Represented By The Se Cretary Of The Department Of Health And Human Services Antigenically reactive regions of the hepatitis a virus polyprotein
DK1021719T3 (da) * 1997-09-22 2007-06-18 Novartis Vaccines & Diagnostic Fremgangsmåde til påvisning af antistoffer i en pröve
DK2204186T3 (en) 1999-02-17 2016-07-18 Csl Ltd Immunogenic complexes, and related methods
CA2391843C (en) * 1999-11-19 2011-10-18 Csl Limited Hcv vaccine compositions
AU2002259130A1 (en) * 2001-05-03 2002-11-18 Eli Lilly And Company Agents for treatment of hcv and methods of use
PT2014671E (pt) * 2002-03-11 2010-06-16 Lab 21 Ltd Métodos e composições para identificar e caracterizar a hepatite c
US7473773B2 (en) * 2004-01-07 2009-01-06 Third Wave Technologies, Inc. Determination of hepatitis C virus genotype
EP1756147A2 (en) * 2004-06-01 2007-02-28 Innogenetics N.V. Peptides for inducing a ctl and/or htl response to hepatitis c virus
US20110136678A1 (en) * 2006-10-20 2011-06-09 Erwin Sablon Methodology for analysis of sequence variations within the hcv ns3/4a genomic region
CA2580589C (en) * 2006-12-19 2016-08-09 Fio Corporation Microfluidic detection system
WO2008119184A1 (en) 2007-04-02 2008-10-09 Fio Corporation System and method of deconvolving multiplexed fluorescence spectral signals generated by quantum dot optical coding technology
CA2692259C (en) 2007-06-22 2012-07-31 Fio Corporation Systems and methods for manufacturing quantum dot-doped polymer microbeads
CN101809433A (zh) * 2007-07-09 2010-08-18 Fio公司 用于增强试样中靶分子荧光检测的系统和方法
US20100257027A1 (en) * 2007-07-23 2010-10-07 Fio Corporation Method and system for collating, storing, analyzing and enabling access to collected and analyzed data associated with biological and environmental test subjects
CN101861203B (zh) * 2007-10-12 2014-01-22 Fio公司 用于形成浓缩体积的微珠的流动聚焦方法和系统以及形成的微珠
CA2729023C (en) 2008-06-25 2013-02-26 Fio Corporation Bio-threat alert system
CN105759021A (zh) 2008-08-29 2016-07-13 Fio公司 用于检测生物和环境检测样品的一次性手持式诊断检测设备和相关系统与方法
RU2578023C2 (ru) 2009-01-13 2016-03-20 Эф-Ай-Оу Корпорейшн Портативный диагностический прибор и способ его применения с электронным устройством и диагностическим картриджем при диагностическом экспресс-исследовании
JP2015534821A (ja) * 2012-11-07 2015-12-07 ギリアード サイエンシーズ， インコーポレイテッド Ｈｃｖ遺伝子型６レプリコン

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE318216T1 (de) * 1987-11-18 1990-06-13 Chiron Corp., Emeryville, Calif. Nanbv-diagnostika und vakzine.
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
JP3114731B2 (ja) * 1990-08-14 2000-12-04 国立感染症研究所長 Ｃ型肝炎ウイルス抗体検出用ペプチド抗原及びその使用方法
CA2070952A1 (en) * 1991-06-11 1992-12-12 Makoto Seki Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
DE4209215A1 (de) * 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
AU671967B2 (en) * 1991-11-21 1996-09-19 Common Services Agency Hepatitis-C virus testing
ES2294779T3 (es) * 1993-04-27 2008-04-01 N.V. Innogenetics S.A. Nuevas secuencias de genotipos del virus de la hepatitis c y su uso como agentes terapeuticos y de diagnostico.
US6881821B2 (en) * 1993-05-05 2005-04-19 Common Services Agency Hepatitis-C virus type 4, 5, and 6
WO1995011918A1 (fr) 1993-10-29 1995-05-04 Srl, Inc. Compose peptidique antigenique et methode de dosage immunologique

Also Published As

Publication number Publication date
US7728121B2 (en) 2010-06-01
ES2231773T3 (es) 2005-05-16
JPH09500009A (ja) 1997-01-07
US20050221296A1 (en) 2005-10-06
JP4171508B2 (ja) 2008-10-22
EP0698101B1 (en) 2004-11-03
DE69434116T2 (de) 2005-10-27
WO1994025602A1 (en) 1994-11-10
EP0698101A1 (en) 1996-02-28
US6881821B2 (en) 2005-04-19
US20080262211A1 (en) 2008-10-23
US7198892B2 (en) 2007-04-03
US7402315B2 (en) 2008-07-22
FI118688B (fi) 2008-02-15
JP2007075119A (ja) 2007-03-29
AU695259B2 (en) 1998-08-13
JP3751315B2 (ja) 2006-03-01
US20070160630A1 (en) 2007-07-12
JP3895747B2 (ja) 2007-03-22
US20050032047A1 (en) 2005-02-10
FI955224A0 (fi) 1995-11-01
AU6579794A (en) 1994-11-21
JP2005124585A (ja) 2005-05-19
DE69434116D1 (en) 2004-12-09
ATE281526T1 (de) 2004-11-15

Similar Documents

Publication Publication Date Title
FI955224L (fi) Hepatiitti-C-virustyypit 4,5 ja 6
FI944310A0 (fi) Heteroaryyliamino- ja heteroaryylisuolfonamidosubstituoituja 3-bentsyyliaminometyylipiperidiinejä ja vastaavia yhdisteitä
FI953351L (fi) Seokset ja niiden käyttö
FI953489A0 (fi) 2,6-diaminopuriinijohdannaisia
FI961599A (fi) 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
NO905438D0 (no) Virusmiddel.
FI940640L (fi) Organoaluminoksituotteet ja käyttö
FI931801L (fi) Peptid-inhibitorer av hi-virusreplikation
FI942369L (fi) Hepatitis-C-virustesti
FI964605L (fi) Hepatiitti-G virus ja sen molekyylikloonaus
FI935728L (fi) Substituoituja 4-fenyylipyridoneja ja 4-fenyyli-2-alkoksipyridiinejä
FI930582L (fi) Nanb-diagnostik: i screening av hepatit c virus anvaendbara polynukleotider
FI944476L (fi) Cartesian-tyyppinen monikantoaaltotakaisinkytkentä
DE59105763D1 (de) Tetra-N-glylcidylverbindung und deren härtbaren Gemische.
FI955605L (fi) Aryloivia lääkkeitä
FI934777A (fi) Multipel hepatitis b virus ytproteiner som bildar partiklar
FI934624A0 (fi) Enantiomera cis-3-(4,6-dihydroxikroman-3-ylmetyl)bensoesyror
FI891941A0 (fi) Uttryckande av hepatitis b pres2-protein i metylotropa jaester.
DK0672234T3 (da) Frysetørringsanlæg
FI943213L (fi) Prosessi valmistaa 3-asyyliestratrieenejä ja asyylibentseenejä
FI961869L (fi) Rokotteen suunnittelu ja valmistus
FI943929L (fi) Hepatiitti C-viruspeptidejä
ATA231194A (de) Häcksler
NO933600D0 (no) Termostabile virus
NO944024D0 (no) 1,2-dihydro-2-okso-pyridin

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 118688

Country of ref document: FI

MA Patent expired